A collaborative study with Harvard Medical School
A Twenty-Patient Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers
Publication Details:
Gilbert K., A Twenty-Patient Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers, E-Poster, Wounds UK Conference 2024
Wound Details
The study focused on diabetic foot ulcers (DFUs), with moderate-to-high exudate levels. The wounds had an average duration of more than 18 weeks
Key Findings and Data:
- Over 4 weeks, MaxioCel led to a 75% reduction in average wound size.
- MaxioCel facilitated autolytic debridement, resulting in a 25% reduction in slough and 31% increase in epithelial tissue.
- MaxioCel effectively absorbed and lock the wound exudate inside the dressing fiber, leading to a 45% increase in healthy periwound skin.
- MaxioCel controls the bleeding during post-debridement.
Key Insights
- MaxioCel demonstrated significant benefits in promoting DFU healing through superior exudate management, antimicrobial action, and biocompatibility.
- Its ability to accelerate wound closure, reduces the risk of infection and amputation, offering both clinical and emotional benefits for patients.
- The dressing’s ease of use and cost-effectiveness make it a valuable addition to DFU treatment protocols, reinforcing the importance of sustainable wound care solutions.
Related Publications
Technology to Support Patient Self Care
Chronic Wound Debridement in an Acute Setting
Severe Pressure Ulcer Debridement in the Acute Sector
A Multi-disciplinary Team Approach to the Management
